台微醫 (6767) 月營收分析比較圖

台微醫 (6767) 月營收報表

年度/月份	營業收入（單位：千元）				累計營業收入（單位：千元）
年度/月份	單月營收	去年同月營收	單月月增率	單月年增率	累計營收	去年累計營收	累積年增率
2024/10	30,801	22,973	9.8%	34.1%	271,165	233,513	16.1%
2024/09	28,062	24,493	-16.9%	14.6%	240,364	210,540	14.2%
2024/08	33,754	25,359	20%	33.1%	212,302	186,047	14.1%
2024/07	28,118	25,371	24.1%	10.8%	178,548	160,688	11.1%
2024/06	22,656	23,964	-23.4%	-5.4%	150,430	135,317	11.2%
2024/05	29,593	24,865	25.4%	19%	127,774	111,353	14.7%
2024/04	23,591	20,984	-16.6%	12.4%	98,181	86,488	13.5%
2024/03	28,292	24,738	55.5%	14.4%	74,590	65,504	13.9%
2024/02	18,193	21,827	-35.3%	-16.6%	46,298	40,766	13.6%
2024/01	28,105	18,939	15.4%	48.4%	28,105	18,939	48.4%
2023/12	24,358	19,160	-1.3%	27.1%	282,538	206,864	36.6%
2023/11	24,667	17,930	7.4%	37.6%	258,180	187,704	37.5%
2023/10	22,973	19,860	-6.2%	15.7%	233,513	169,774	37.5%
2023/09	24,493	17,956	-3.4%	36.4%	210,540	149,914	40.4%
2023/08	25,359	18,706	0%	35.6%	186,047	131,958	41%
2023/07	25,371	20,014	5.9%	26.8%	160,688	113,252	41.9%
2023/06	23,964	19,017	-3.6%	26%	135,317	93,238	45.1%
2023/05	24,865	17,248	18.5%	44.2%	111,353	74,221	50%
2023/04	20,984	13,834	-15.2%	51.7%	86,488	56,973	51.8%
2023/03	24,738	17,117	13.3%	44.5%	65,504	43,139	51.8%
2023/02	21,827	8,074	15.2%	170.3%	40,766	26,022	56.7%
2023/01	18,939	17,948	-1.1%	5.5%	18,939	17,948	5.5%
2022/12	19,160	17,521	6.9%	9.4%	206,864	144,499	43.2%
2022/11	17,930	14,967	-9.7%	19.8%	187,704	126,978	47.8%
2022/10	19,860	13,175	10.6%	50.7%	169,774	112,011	51.6%
2022/09	17,956	12,723	-4%	41.1%	149,914	98,836	51.7%
2022/08	18,706	13,371	-6.5%	39.9%	131,958	86,113	53.2%
2022/07	20,014	12,256	5.2%	63.3%	113,252	72,742	55.7%
2022/06	19,017	11,770	10.3%	61.6%	93,238	60,486	54.1%
2022/05	17,248	9,500	24.7%	81.6%	74,221	48,716	52.3%
2022/04	13,834	12,236	-19.2%	13.1%	56,973	39,216	45.3%
2022/03	17,117	11,140	112%	53.7%	43,139	26,980	59.9%
2022/02	8,074	6,390	-55%	26.4%	26,022	15,840	64.3%
2022/01	17,948	9,450	2.4%	89.9%	17,948	9,450	89.9%
2021/12	17,521	11,825	17.1%	48.2%	144,499	102,368	41.2%
2021/11	14,967	9,218	13.6%	62.4%	126,978	90,543	40.2%